IL119225A - Pharmaceutical compositions for the treatment of asthma in mammals - Google Patents

Pharmaceutical compositions for the treatment of asthma in mammals

Info

Publication number
IL119225A
IL119225A IL11922596A IL11922596A IL119225A IL 119225 A IL119225 A IL 119225A IL 11922596 A IL11922596 A IL 11922596A IL 11922596 A IL11922596 A IL 11922596A IL 119225 A IL119225 A IL 119225A
Authority
IL
Israel
Prior art keywords
asthma
mammals
treatment
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
IL11922596A
Other languages
English (en)
Other versions
IL119225A0 (en
Original Assignee
Cellular Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellular Sciences Inc filed Critical Cellular Sciences Inc
Publication of IL119225A0 publication Critical patent/IL119225A0/xx
Publication of IL119225A publication Critical patent/IL119225A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11922596A 1995-09-19 1996-09-09 Pharmaceutical compositions for the treatment of asthma in mammals IL119225A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US396295P 1995-09-19 1995-09-19

Publications (2)

Publication Number Publication Date
IL119225A0 IL119225A0 (en) 1996-12-05
IL119225A true IL119225A (en) 2000-09-28

Family

ID=21708422

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11922596A IL119225A (en) 1995-09-19 1996-09-09 Pharmaceutical compositions for the treatment of asthma in mammals

Country Status (10)

Country Link
EP (1) EP0804181A4 (de)
JP (1) JP4459303B2 (de)
AU (1) AU719332B2 (de)
CA (1) CA2205112C (de)
IL (1) IL119225A (de)
MX (1) MX9703653A (de)
NZ (1) NZ306832A (de)
TW (1) TW434012B (de)
WO (1) WO1997010818A1 (de)
ZA (1) ZA967833B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146391A0 (en) * 1999-05-14 2002-07-25 Cellular Sciences Inc Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
CA2440480A1 (en) * 2001-03-15 2002-09-26 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
US6689810B2 (en) * 2001-08-21 2004-02-10 Cellular Sciences, Inc. Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
US6623723B2 (en) * 2001-08-21 2003-09-23 Cellular Sciences Inc. Method for treating bronchial constriction and bronchospasm
US20030105162A1 (en) * 2001-08-21 2003-06-05 Celluar Sciences, Inc. Method for treating bronchial constriction and bronchospasm
US8076373B2 (en) * 2001-09-11 2011-12-13 North Cell Pharmacetical Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
WO2009116546A1 (ja) * 2008-03-18 2009-09-24 国立大学法人 岡山大学 興奮性化学伝達調節剤およびそのスクリーニング法
US11571455B2 (en) 2013-04-11 2023-02-07 Vanderbilt University Methods and compositions for treating alcoholic liver disease
US11771739B2 (en) 2017-06-16 2023-10-03 Vanderbilt University Methods and compositions for treating microbial inflammation
EP3797766A1 (de) * 2019-09-24 2021-03-31 Evonik Operations GmbH Zusammensetzungen zur verwendung bei der reduzierung von entzündungen
CN114641562B (zh) * 2019-11-14 2025-07-08 默克专利股份公司 细胞培养基
US20240189266A1 (en) * 2021-05-04 2024-06-13 The Board Of Trustees Of The Leland Stanford Junior University Lactoyl Amino Acids for the Treatment of Metabolic Disease
CN119013010A (zh) * 2021-12-16 2024-11-22 艾维尔勒斯生物公司 用于治疗慢性肺病的可吸入或可摄入的乳酸组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1857M (fr) * 1962-03-08 1963-06-10 Roussel Uclaf Nouveau médicament notamment pour le traitement des maladies d'origine virale.
US3279997A (en) * 1963-10-22 1966-10-18 Herbert D Schneyer Enteric coated calcium lactate tablets containing an antihistamine and thiamine chloride
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US3988470A (en) * 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
US4158057A (en) * 1975-03-28 1979-06-12 Stanko Ronald T Prevention of the accumulation of fatty deposits in the liver
US4197316A (en) * 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4351835A (en) * 1981-04-01 1982-09-28 Montefiore Hospital Method for preventing body fat deposition in mammals
US4415576A (en) * 1981-04-01 1983-11-15 Montefiore Hospital Method for preventing body fat deposition in mammals
US4521375A (en) * 1982-11-23 1985-06-04 Coopervision, Inc. Sterilizing treatment with hydrogen peroxide and neutralization of residual amounts thereof
DE3302694A1 (de) * 1983-01-27 1984-08-02 Retheto Filmtechnik Theilemann & Co, 8000 München Mundpflegemittel
CA1264442A (en) * 1984-06-22 1990-01-16 Richard L. Veech Electrolyte solutions and in vivo use thereof
US4696917A (en) * 1985-08-01 1987-09-29 Lindstrom Richard L Irrigation solution
JPS63135370A (ja) * 1986-11-26 1988-06-07 Grelan Pharmaceut Co Ltd 抗アレルギ−剤
IN168530B (de) * 1987-11-06 1991-04-20 Lyphomed Inc
WO1990000900A1 (en) * 1988-07-20 1990-02-08 Amgen Inc. Method of treating inflammatory disorders by reducing phagocyte activation
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤
FI915643A7 (fi) * 1990-03-30 1991-11-29 Amgen Inc Hengityspurkausta vaimentava tekijä
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5296370A (en) * 1990-10-04 1994-03-22 Rutgers, The State University Repair medium for the resuscitation of injured cells
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
CA2129732A1 (en) * 1992-02-25 1993-09-02 Alain Martin Cytoprotective compositions containing pyruvate and antioxidants
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
JP3236658B2 (ja) * 1992-04-27 2001-12-10 花王株式会社 気管支拡張剤
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof

Also Published As

Publication number Publication date
TW434012B (en) 2001-05-16
AU6915996A (en) 1997-04-09
CA2205112A1 (en) 1997-03-27
IL119225A0 (en) 1996-12-05
NZ306832A (en) 2001-04-27
ZA967833B (en) 1997-06-02
MX9703653A (es) 1998-07-31
EP0804181A1 (de) 1997-11-05
JPH10509463A (ja) 1998-09-14
AU719332B2 (en) 2000-05-04
CA2205112C (en) 2008-11-18
EP0804181A4 (de) 2005-02-02
WO1997010818A1 (en) 1997-03-27
JP4459303B2 (ja) 2010-04-28

Similar Documents

Publication Publication Date Title
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
IL121170A0 (en) Compositions for the treatment of dermatological disorders
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
IL117656A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
GB9418609D0 (en) Pharmaceutical compositions
HUP9903684A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating depression
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
IL117655A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
IL113057A0 (en) Compositions for the treatment of dandruff
ZA959081B (en) Pharmaceutical compositions
EP0868430A4 (de) Therapeutische zusammensetzungen
HU9400096D0 (en) Pharmaceutical compositions
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
GB9400047D0 (en) Pharmaceutical compositions
KR100248098B1 (en) Pharmaceutical composition for the treatment of dementia
HUP9903685A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating excessive aggression
GB9707483D0 (en) Pharmaceutical compositions
ZA952332B (en) Aminoalkyl benzothiazolinones process for their preparation and the pharmaceutical compositions which contain them
IL116680A0 (en) Pharmaceutical composition for the treatment of depression
GB9404928D0 (en) Pharmaceutical compositions and method of producing the same
IL119219A0 (en) Pharmaceutical compositions for treatment of the eyes

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees